Table 3:
Potential benefits of enhanced convergence medicine opportunities
| Stakeholder | Benefit | Examples |
|---|---|---|
| Medical doctors | Professional development | Greater job satisfaction due to creativity and novel learning; new challenges; diversified skill-set. Greater appreciation and understanding for clinical, research and commercialization procedures. |
| Non-medical researchers and innovators | Professional development | Greater job satisfaction due to creativity and novel learning; enhanced access to clinical care processes and procedures; greater appreciation for the clinical care environment; greater exposure to commercialization processes and opportunities. |
| Enhanced clinical practice | Diversified and up-skilled workforce; greater workforce satisfaction; improved clinical innovations and hence patient outcomes. | |
| Employing health service | Mutually beneficial partnerships | Partnering with other public and private organizations; potential for economic development from commercial successes. |
| Recruitment and retention | Enhanced workforce retention | |
| Research institutions | Improved novelty of research | Increases in transdisciplinary research work. Increased opportunities for commercialization. |
| Private enterprises | Improved access to translational research innovations | Increased engagement of clinicians and researchers in commercialization pursuits. Increased economic opportunities. |
| Community | Improved standards of health care | Greater innovation from researchers, clinicians and private enterprises. |